Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Manufacturing
Par Health recalls more IV bags for presence of cellulose
Par Health issued a voluntary recall of two lots of the IV barbiturate Brevital sodium that may be tainted with cellulose.
Joseph Keenan
Oct 12, 2026 9:04am
GSK pledges $800M to upgrade its R&D, manufacturing in PA
Oct 9, 2026 4:13pm
National Fragility Index spotlights drug supply-chain problems
Oct 7, 2026 10:15am
BD snags tariff relief with $19B US investment pledge
Oct 6, 2026 7:42am
Novo cites production site corrections amid hemophilia FDA delay
Oct 5, 2026 7:15am
Bayer doubles down on US with $2.2B Ohio manufacturing project
Oct 2, 2026 3:10pm